Missed Opportunities in HIV Testing in Turkiye: Implications for Late Diagnoses

Basit Öğe Kaydı
dc.authoridOzkaya, Hacer Deniz/0000-0002-5212-9629
dc.contributor.authorOzkaya, Hacer Deniz
dc.contributor.authorElazab, Khaled
dc.contributor.authorTuran, Buelent
dc.contributor.authorNazlo, Arzu
dc.contributor.authorOzturk, Barcin
dc.contributor.authorPullukcu, Husnu
dc.contributor.authorGokengin, Deniz
dc.date.accessioned2025-03-20T09:50:54Z
dc.date.available2025-03-20T09:50:54Z
dc.date.issued2024
dc.departmentİzmir Bakırçay Üniversitesi
dc.description.abstractBackground: Late diagnosis of HIV infection is a major global problem. In Turkiye, only 41%-50% of people living with HIV are diagnosed, suggesting that many opportunities for HIV testing might be missed. Setting: The aim of this study was to determine the missed testing opportunities for HIV in healthcare settings in Turkiye and the predictors for missed opportunities (MOs). Methods: The study included patients with a new HIV diagnosis, presenting to care between January 2018 and December 2020. They were given a verbal questionnaire face to face, by a telephone call or an online meeting for visits to a health care setting within the year before their diagnosis. Electronic medical records were also examined. Results: The sample included 198 patients with at least 1 visit to any health care setting, with a total of 1677 visits. Patients had an indication for HIV testing in 51.3% (861/1677) of the visits; an HIV test was not offered in 77.9% (671/861) and was considered a MO. The highest number of MOs was in emergency departments (59.8%) (180/301). The most common reason for visiting was constitutional symptoms and indicator conditions (55.4%) (929/1677). University graduates and those with a CD4+ T-cell count <200/mm3 were more likely to have a MO. Conclusions: Many opportunities to diagnose HIV at an early stage are missed in health care settings in Turkiye. Considering the rapidly increasing number of new diagnoses in the last decade, urgent action needs to be taken.
dc.identifier.doi10.1097/QAI.0000000000003398
dc.identifier.endpage84
dc.identifier.issn1525-4135
dc.identifier.issn1077-9450
dc.identifier.issue1
dc.identifier.pmid38346425
dc.identifier.scopus2-s2.0-85190420638
dc.identifier.scopusqualityQ2
dc.identifier.startpage77
dc.identifier.urihttps://doi.org/10.1097/QAI.0000000000003398
dc.identifier.urihttps://hdl.handle.net/20.500.14034/2364
dc.identifier.volume96
dc.identifier.wosWOS:001233719100001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofJaids-Journal of Acquired Immune Deficiency Syndromes
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250319
dc.subjectHIV testing
dc.subjectmissed opportunities
dc.subjectHIV indicator conditions
dc.subjectlate HIV diagnosis
dc.titleMissed Opportunities in HIV Testing in Turkiye: Implications for Late Diagnoses
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu